EP3838274
PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALINE DERIVATIVE FOR USE IN THE TREATMENT OF CNS DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.1.2017EP published:
1.11.2023EP application number:
20215786.3
EPO information:
European Patent Register
Max expiry date:
25.1.2037
Title in English:
PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALINE DERIVATIVE FOR USE IN THE TREATMENT OF CNS DISORDERSLanguage of the patent:
English
Timeline
Today
26.1.2017EP application
1.11.2023EP Publication
Owner
Name:
Intra-Cellular Therapies, Inc.Address:
430 East 29th Street, Suite 900, New York, NY 10016, US
Inventor
Name:
LI, PengAddress:
New York, New York 10016, US
Name:
YAO, WeiAddress:
New York, New York 10016, US
Priority
Number:
201662287264 PDate:
26.1.2016Country:
US
Number:
201662440130 PDate:
29.12.2016Country:
US
Classification
Categories:
A61K 31/445, A61K 31/4985, A61P 25/00